Detalles de la búsqueda
1.
Impacts of CYP2C19 genetic polymorphisms on bioavailability and effect on platelet adhesion of vicagrel, a novel thienopyridine P2Y12 inhibitor.
Br J Clin Pharmacol
; 86(9): 1860-1874, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32267573
2.
A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjectsâ©.
Int J Clin Pharmacol Ther
; 57(3): 167-174, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663977
3.
Diversity of evolution in MDR monophasic S. Typhimurium among food animals and food products in Southern China from 2011 to 2018.
Int J Food Microbiol
; 412: 110572, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38237416
4.
Safety and pharmacokinetics of a new biosimilar trastuzumab (HL02): a Phase I bioequivalence study in healthy Chinese men.
Expert Opin Biol Ther
; 22(2): 179-186, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616478
5.
First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults.
Front Pharmacol
; 12: 689523, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34366847
6.
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects.
Front Pharmacol
; 12: 646171, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34122068
7.
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Ascending Dose and Food Effect Study to Evaluate the Tolerance, Pharmacokinetics of Jaktinib, a New Selective Janus Kinase Inhibitor in Healthy Chinese Volunteers.
Front Pharmacol
; 11: 604314, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33536914
8.
A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men.
Front Pharmacol
; 11: 609522, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33569002
9.
Tolerance, variability, and pharmacokinetics of bevacizumab biosimilars in Chinese healthy male subjects.
Cancer Chemother Pharmacol
; 82(4): 615-623, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30043208
10.
Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers.
Front Pharmacol
; 9: 643, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29973877
Resultados
1 -
10
de 10
1
Próxima >
>>